Pacer Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-558,197
| Closed | -$50.7M | – | 3613 |
|
2024
Q4 | $50.7M | Buy |
558,197
+553,435
| +11,622% | +$50.2M | 0.11% | 195 |
|
2024
Q3 | $460K | Sell |
4,762
-122
| -2% | -$11.8K | ﹤0.01% | 1645 |
|
2024
Q2 | $448K | Buy |
4,884
+22
| +0.5% | +$2.02K | ﹤0.01% | 1598 |
|
2024
Q1 | $448K | Sell |
4,862
-42
| -0.9% | -$3.87K | ﹤0.01% | 1583 |
|
2023
Q4 | $466K | Buy |
4,904
+2,174
| +80% | +$207K | ﹤0.01% | 1547 |
|
2023
Q3 | $255K | Sell |
2,730
-3,070
| -53% | -$287K | ﹤0.01% | 1401 |
|
2023
Q2 | $530K | Buy |
5,800
+4,470
| +336% | +$409K | ﹤0.01% | 1452 |
|
2023
Q1 | $97.8K | Sell |
1,330
-4,884
| -79% | -$359K | ﹤0.01% | 1601 |
|
2022
Q4 | $519K | Buy |
6,214
+4,306
| +226% | +$360K | ﹤0.01% | 1224 |
|
2022
Q3 | $185K | Buy |
+1,908
| New | +$185K | ﹤0.01% | 1671 |
|
2022
Q2 | – | Sell |
-1,368
| Closed | -$236K | – | 2380 |
|
2022
Q1 | $236K | Sell |
1,368
-2,057
| -60% | -$355K | ﹤0.01% | 2071 |
|
2021
Q4 | $554K | Sell |
3,425
-1,324
| -28% | -$214K | 0.01% | 1513 |
|
2021
Q3 | $708K | Buy |
4,749
+1,095
| +30% | +$163K | 0.01% | 991 |
|
2021
Q2 | $895K | Sell |
3,654
-25
| -0.7% | -$6.12K | 0.01% | 899 |
|
2021
Q1 | $974K | Sell |
3,679
-114
| -3% | -$30.2K | 0.02% | 787 |
|
2020
Q4 | $1.11M | Sell |
3,793
-4,024
| -51% | -$1.18M | 0.02% | 654 |
|
2020
Q3 | $1.85M | Buy |
+7,817
| New | +$1.85M | 0.04% | 435 |
|
2020
Q1 | – | Sell |
-10,958
| Closed | -$1.83M | – | 678 |
|
2019
Q4 | $1.83M | Sell |
10,958
-714
| -6% | -$119K | 0.08% | 297 |
|
2019
Q3 | $1.53M | Sell |
11,672
-40
| -0.3% | -$5.24K | 0.03% | 633 |
|
2019
Q2 | $1.42M | Buy |
+11,712
| New | +$1.42M | 0.03% | 659 |
|